Case Report: Active tuberculosis infection in CAR T-cell recipients post CAR T-cell therapy: a retrospective case series

High response rates in B-cell malignancies have been achieved with chimeric antigen receptor (CAR) T-cell therapy. Emerging reports indicate a risk of active tuberculosis (TB) with novel immunotherapy for tumors. However, studies of TB in patients post CAR T-cell therapy are limited. In this case se...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Peiling, Huang, Liang, Zheng, Miao, Zhang, Chao, Wan, Dongyi, Wei, Jia, Cao, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210154/
https://www.ncbi.nlm.nih.gov/pubmed/37249982
http://dx.doi.org/10.3389/fcimb.2023.1147454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210154/
https://www.ncbi.nlm.nih.gov/pubmed/37249982
http://dx.doi.org/10.3389/fcimb.2023.1147454

Ejemplares similares